{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T09:43:36Z","timestamp":1791020616862,"version":"4.1.0"},"reference-count":97,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2012,12,12]],"date-time":"2012-12-12T00:00:00Z","timestamp":1355270400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0051793","type":"journal-article","created":{"date-parts":[[2012,12,12]],"date-time":"2012-12-12T22:08:20Z","timestamp":1355350100000},"page":"e51793","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":65,"title":["Excess Soluble CD40L Contributes to Blood Brain Barrier Permeability In Vivo: Implications for HIV-Associated Neurocognitive Disorders"],"prefix":"10.1371","volume":"7","author":[{"given":"Donna C.","family":"Davidson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Hirschman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meera V.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Kasischke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay B.","family":"Maggirwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,12,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jlb.67.1.2","article-title":"CD40-CD40 ligand","volume":"67","author":"C van Kooten","year":"2000","journal-title":"J Leukoc Biol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"7025","DOI":"10.1074\/jbc.270.13.7025","article-title":"Recombinant soluble trimeric CD40 ligand is biologically active","volume":"270","author":"GJ Mazzei","year":"1995","journal-title":"J Biol Chem"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1161\/01.CIR.0000028962.04520.01","article-title":"Platelet-derived CD40L: the switch-hitting player of cardiovascular disease","volume":"106","author":"P Andre","year":"2002","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1096\/fasebj.12.1.79","article-title":"Enhanced activation of platelets with abnormal release of RANTES in human immunodeficiency virus type 1 infection","volume":"12","author":"PA Holme","year":"1998","journal-title":"FASEB J"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/QAI.0b013e3182439355","article-title":"Increased platelet and microparticle activation in HIV infection: upregulation of P-selectin and tissue factor expression","volume":"59","author":"E Mayne","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s13365-011-0053-2","article-title":"Platelet decline as a predictor of brain injury in HIV infection","volume":"17","author":"AB Ragin","year":"2011","journal-title":"J Neurovirol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1001\/archneur.64.9.1264","article-title":"Platelet decline: an avenue for investigation into the pathogenesis of human immunodeficiency virus -associated dementia","volume":"64","author":"LM Wachtman","year":"2007","journal-title":"Arch Neurol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.4049\/jimmunol.178.5.3226","article-title":"Functional synergy between CD40 ligand and HIV-1 Tat contributes to inflammation: implications in HIV type 1 dementia","volume":"178","author":"Z Sui","year":"2007","journal-title":"J Immunol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"9454","DOI":"10.1523\/JNEUROSCI.5796-09.2010","article-title":"Dyad of CD40\/CD40 ligand fosters neuroinflammation at the blood-brain barrier and is regulated via JNK signaling: implications for HIV-1 encephalitis","volume":"30","author":"SH Ramirez","year":"2010","journal-title":"J Neurosci"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nrd2368","article-title":"Modelling of the blood-brain barrier in drug discovery and development","volume":"6","author":"R Cecchelli","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/13550280490463532","article-title":"Inflammatory changes and breakdown of microvascular integrity in early human immunodeficiency virus dementia","volume":"10","author":"MJ Avison","year":"2004","journal-title":"J Neurovirol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/35073667","article-title":"Pathways to neuronal injury and apoptosis in HIV-associated dementia","volume":"410","author":"M Kaul","year":"2001","journal-title":"Nature"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00401-010-0718-6","article-title":"The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia","volume":"120","author":"C Iadecola","year":"2010","journal-title":"Acta Neuropathol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1212\/WNL.0b013e318200d727","article-title":"HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study","volume":"75","author":"RK Heaton","year":"2010","journal-title":"Neurology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/QAD.0b013e3283354a7b","article-title":"Cognitive dysfunction in HIV patients despite long-standing suppression of viremia","volume":"24","author":"S Simioni","year":"2010","journal-title":"AIDS"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nri1527","article-title":"The neuropathogenesis of AIDS","volume":"5","author":"F Gonzalez-Scarano","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1001\/jama.282.17.1627","article-title":"Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy","volume":"282","author":"G Dornadula","year":"1999","journal-title":"JAMA"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1086\/527324","article-title":"Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy","volume":"197","author":"TW Chun","year":"2008","journal-title":"J Infect Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1172\/JCI26197","article-title":"HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir","volume":"115","author":"TW Chun","year":"2005","journal-title":"J Clin Invest"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2217\/17469600.2.3.271","article-title":"Developing neuroprotective strategies for treatment of HIV-associated neurocognitive dysfunction","volume":"2","author":"JA Rumbaugh","year":"2008","journal-title":"Futur HIV Ther"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/WCO.0b013e328329cf3c","article-title":"HIV-1 associated dementia: update on pathological mechanisms and therapeutic approaches","volume":"22","author":"M Kaul","year":"2009","journal-title":"Curr Opin Neurol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/ana.21697","article-title":"Extensive astrocyte infection is prominent in human immunodeficiency virus-associated dementia","volume":"66","author":"MJ Churchill","year":"2009","journal-title":"Ann Neurol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1128\/JVI.71.3.2495-2499.1997","article-title":"Molecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells","volume":"71","author":"M Ma","year":"1997","journal-title":"J Virol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1016\/j.vaccine.2003.12.013","article-title":"Strong T cell type-1 immune responses to HIV-1 Tat (1-72) protein-coated nanoparticles","volume":"22","author":"Z Cui","year":"2004","journal-title":"Vaccine"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1096\/fj.05-5619fje","article-title":"Interaction of HIV Tat and matrix metalloproteinase in HIV neuropathogenesis: a new host defense mechanism","volume":"20","author":"J Rumbaugh","year":"2006","journal-title":"FASEB J"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"12604","DOI":"10.1523\/JNEUROSCI.2958-08.2008","article-title":"Human immunodeficiency virus protein Tat induces synapse loss via a reversible process that is distinct from cell death","volume":"28","author":"HJ Kim","year":"2008","journal-title":"J Neurosci"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"14153","DOI":"10.1523\/JNEUROSCI.1042-10.2010","article-title":"Human immunodeficiency virus-1 Tat activates calpain proteases via the ryanodine receptor to enhance surface dopamine transporter levels and increase transporter-specific uptake and Vmax","volume":"30","author":"SW Perry","year":"2010","journal-title":"J Neurosci"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"584","DOI":"10.4049\/jimmunol.1001911","article-title":"Antiplatelet activity of valproic acid contributes to decreased soluble CD40 ligand production in HIV type 1-infected individuals","volume":"186","author":"DC Davidson","year":"2011","journal-title":"J Immunol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1084\/jem.180.5.1889","article-title":"Humoral immune responses in CD40 ligand-deficient mice","volume":"180","year":"1994","journal-title":"J Exp Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S1074-7613(03)00324-8","article-title":"CD40, but not CD40L, is required for the optimal priming of T cells and control of aerosol M. tuberculosis infection","volume":"19","author":"V Lazarevic","year":"2003","journal-title":"Immunity"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0002-9440(10)61744-0","article-title":"Role of CD40-CD40L in mouse severe malaria","volume":"159","author":"PF Piguet","year":"2001","journal-title":"Am J Pathol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.1182\/blood.V92.11.4472","article-title":"Recombinant CD40L treatment protects allogeneic murine bone marrow transplant recipients from death caused by herpes simplex virus-1 infection","volume":"92","author":"JL Beland","year":"1998","journal-title":"Blood"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1161\/ATVBAHA.110.216143","article-title":"Enhanced levels of soluble CD40 ligand exacerbate platelet aggregation and thrombus formation through a CD40-dependent tumor necrosis factor receptor-associated factor-2\/Rac1\/p38 mitogen-activated protein kinase signaling pathway","volume":"30","author":"D Yacoub","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1182\/blood.V95.3.886.003k45_886_893","article-title":"Structural and functional characterization of the mouse von Willebrand factor receptor GPIb-IX with novel monoclonal antibodies","volume":"95","author":"W Bergmeier","year":"2000","journal-title":"Blood"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1182\/blood.V96.7.2520","article-title":"Identification of critical antigen-specific mechanisms in the development of immune thrombocytopenic purpura in mice","volume":"96","author":"B Nieswandt","year":"2000","journal-title":"Blood"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/jcbfm.2010.158","article-title":"Two-photon NADH imaging exposes boundaries of oxygen diffusion in cortical vascular supply regions","volume":"31","author":"KA Kasischke","year":"2011","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.brainres.2010.12.017","article-title":"Methamphetamine causes sustained depression in cerebral blood flow","volume":"1373","author":"O Polesskaya","year":"2011","journal-title":"Brain Res"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Polesskaya O, Sun A, Salahura G, Silva JN, Dewhurst S, <etal>et al<\/etal>.. (2012) Detection of Microregional Hypoxia in Mouse Cerebral Cortex by Two-photon Imaging of Endogenous NADH Fluorescence. J Vis Exp.","DOI":"10.3791\/3466"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bcp.2004.10.003","article-title":"Protective effect of dextromethorphan against endotoxic shock in mice","volume":"69","author":"G Li","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1002\/jnr.21973","article-title":"Vessel microport technique for applications in cerebrovascular research","volume":"87","author":"L Chen","year":"2009","journal-title":"J Neurosci Res"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00018-009-0209-x","article-title":"Platelets and viruses: an ambivalent relationship","volume":"67","author":"C Flaujac","year":"2010","journal-title":"Cell Mol Life Sci"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2174\/157016208785861140","article-title":"Platelets and HIV-1 infection: old and new aspects","volume":"6","author":"D Torre","year":"2008","journal-title":"Curr HIV Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1161\/01.CIR.0000160349.42665.0C","article-title":"CD40\/CD40 ligand signaling in mouse cerebral microvasculature after focal ischemia\/reperfusion","volume":"111","author":"M Ishikawa","year":"2005","journal-title":"Circulation"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1126\/science.1175202","article-title":"Identification of splenic reservoir monocytes and their deployment to inflammatory sites","volume":"325","author":"FK Swirski","year":"2009","journal-title":"Science"},{"key":"ref45","unstructured":"Beck WS (1991) Hematology. Cambridge, Mass.: MIT Press. xvi, 667 p."},{"key":"ref46","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/ajh.2830340302","article-title":"Properties of the exchangeable splenic platelets released into the circulation during exercise-induced thrombocytosis","volume":"34","author":"KG Chamberlain","year":"1990","journal-title":"Am J Hematol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1002\/eji.1830250639","article-title":"A soluble form of TRAP (CD40 ligand) is rapidly released after T cell activation","volume":"25","author":"D Graf","year":"1995","journal-title":"Eur J Immunol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1189\/jlb.0307191","article-title":"Monocyte subpopulations and their differentiation patterns during infection","volume":"82","author":"D Strauss-Ayali","year":"2007","journal-title":"J Leukoc Biol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S1074-7613(03)00174-2","article-title":"Blood monocytes consist of two principal subsets with distinct migratory properties","volume":"19","author":"F Geissmann","year":"2003","journal-title":"Immunity"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/nri1733","article-title":"Monocyte and macrophage heterogeneity","volume":"5","author":"S Gordon","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"L812","DOI":"10.1152\/ajplung.00092.2011","article-title":"Regulation of monocyte subset proinflammatory responses within the lung microvasculature by the p38 MAPK\/MK2 pathway","volume":"301","author":"KP O\u2019Dea","year":"2011","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.4049\/jimmunol.1000772","article-title":"Tumor cell-released TLR4 ligands stimulate Gr-1+CD11b+F4\/80+ cells to induce apoptosis of activated T cells","volume":"185","author":"YY Liu","year":"2010","journal-title":"J Immunol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1189\/jlb.1107768","article-title":"Glucocorticoids induce an activated, anti-inflammatory monocyte subset in mice that resembles myeloid-derived suppressor cells","volume":"84","author":"G Varga","year":"2008","journal-title":"J Leukoc Biol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrn3114","article-title":"Neurovascular pathways to neurodegeneration in Alzheimer\u2019s disease and other disorders","volume":"12","author":"BV Zlokovic","year":"2011","journal-title":"Nat Rev Neurosci"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1189\/jlb.0811394","article-title":"Monocyte maturation, HIV susceptibility, and transmigration across the blood brain barrier are critical in HIV neuropathogenesis","volume":"91","author":"DW Williams","year":"2012","journal-title":"J Leukoc Biol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1538-7836.2010.04168.x","article-title":"HIV-1 Tat-induced platelet activation and release of CD154 contribute to HIV-1-associated autoimmune thrombocytopenia","volume":"9","author":"J Wang","year":"2011","journal-title":"J Thromb Haemost"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/1521-4141(200102)31:2<376::AID-IMMU376>3.0.CO;2-5","article-title":"Tat-induced platelet-activating factor synthesis contributes to the angiogenic effect of HIV-1 Tat","volume":"31","author":"L Del Sorbo","year":"2001","journal-title":"Eur J Immunol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/(SICI)1521-4141(199905)29:05<1513::AID-IMMU1513>3.0.CO;2-X","article-title":"The synthesis of platelet-activating factor modulates chemotaxis of monocytes induced by HIV-1 Tat","volume":"29","author":"L Del Sorbo","year":"1999","journal-title":"Eur J Immunol"},{"key":"ref59","first-page":"167","article-title":"Release of soluble CD40 ligand after platelet activation: studies on the solubilization phase","volume":"114","author":"K Otterdal","year":"2004","journal-title":"Thromb Res"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/09537100020031207","article-title":"Platelet CD40 ligand (CD40L)\u2013subcellular localization, regulation of expression, and inhibition by clopidogrel","volume":"12","author":"A Hermann","year":"2001","journal-title":"Platelets"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.molmed.2008.09.006","article-title":"CD40-CD40 ligand interactions in oxidative stress, inflammation and vascular disease","volume":"14","author":"M Rizvi","year":"2008","journal-title":"Trends Mol Med"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2174\/187152710791012099","article-title":"Impact of the CD40-CD40L dyad in Alzheimer\u2019s disease","volume":"9","author":"B Giunta","year":"2010","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1126\/science.286.5448.2352","article-title":"Microglial activation resulting from CD40-CD40L interaction after beta-amyloid stimulation","volume":"286","author":"J Tan","year":"1999","journal-title":"Science"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0165-5728(99)00053-3","article-title":"Activation of microglial cells by the CD40 pathway: relevance to multiple sclerosis","volume":"97","author":"J Tan","year":"1999","journal-title":"J Neuroimmunol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/nn968","article-title":"Role of CD40 ligand in amyloidosis in transgenic Alzheimer\u2019s mice","volume":"5","author":"J Tan","year":"2002","journal-title":"Nat Neurosci"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0002-9440(10)64875-4","article-title":"CD40-CD40L interactions induce chemokine expression by human microglia: implications for human immunodeficiency virus encephalitis and multiple sclerosis","volume":"160","author":"TG D\u2019Aversa","year":"2002","journal-title":"Am J Pathol"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/35393","article-title":"CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells","volume":"391","author":"V Henn","year":"1998","journal-title":"Nature"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"18307","DOI":"10.1074\/jbc.M700211200","article-title":"CD40-40L signaling in vascular inflammation","volume":"282","author":"S Chakrabarti","year":"2007","journal-title":"J Biol Chem"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1182\/blood-2008-03-143479","article-title":"Soluble CD40 ligand induces endothelial dysfunction in human and porcine coronary artery endothelial cells","volume":"112","author":"C Chen","year":"2008","journal-title":"Blood"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/01.CIR.0000027107.54614.1A","article-title":"CD40 ligand inhibits endothelial cell migration by increasing production of endothelial reactive oxygen species","volume":"106","author":"C Urbich","year":"2002","journal-title":"Circulation"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.4049\/jimmunol.0801734","article-title":"Functional blocking monoclonal antibodies against IL-12p40 homodimer inhibit adoptive transfer of experimental allergic encephalomyelitis","volume":"182","author":"S Mondal","year":"2009","journal-title":"J Immunol"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0006-8993(01)01992-8","article-title":"Nitric-oxide-induced inhibition of glyceraldehyde-3-phosphate dehydrogenase may mediate reduced endothelial cell monolayer integrity in an in vitro model blood-brain barrier","volume":"894","author":"RD Hurst","year":"2001","journal-title":"Brain Res"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1046\/j.1471-4159.1997.68030991.x","article-title":"Lysophosphatidic acid increases tight junction permeability in cultured brain endothelial cells","volume":"68","author":"C Schulze","year":"1997","journal-title":"J Neurochem"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1242\/jcs.108.2.609","article-title":"Evidence that tyrosine phosphorylation may increase tight junction permeability","volume":"2)","author":"JM Staddon","year":"1995","journal-title":"J Cell Sci 108 ( Pt"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev-med-042909-093756","article-title":"HIV infection, inflammation, immunosenescence, and aging","volume":"62","author":"SG Deeks","year":"2011","journal-title":"Annu Rev Med"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/QAI.0b013e3181e66216","article-title":"Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort","volume":"55","author":"PC Tien","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/path.2276","article-title":"Immune activation and inflammation in HIV-1 infection: causes and consequences","volume":"214","author":"V Appay","year":"2008","journal-title":"J Pathol"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0166-2236(00)02004-X","article-title":"Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier","volume":"24","author":"JD Huber","year":"2001","journal-title":"Trends Neurosci"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2003.12.016","article-title":"The blood-brain barrier: an overview: structure, regulation, and clinical implications","volume":"16","author":"P Ballabh","year":"2004","journal-title":"Neurobiol Dis"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/WCO.0b013e32834695fb","article-title":"Current understanding of HIV-associated neurocognitive disorders pathogenesis","volume":"24","author":"P Gannon","year":"2011","journal-title":"Curr Opin Neurol"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"17098","DOI":"10.1074\/jbc.274.24.17098","article-title":"Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes. A hit and run phenomenon","volume":"274","author":"A Nath","year":"1999","journal-title":"J Biol Chem"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"11466","DOI":"10.1073\/pnas.97.21.11466","article-title":"Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1","volume":"97","author":"H Xiao","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1126\/science.285.5433.1569","article-title":"In vivo protein transduction: delivery of a biologically active protein into the mouse","volume":"285","author":"SR Schwarze","year":"1999","journal-title":"Science"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"12190","DOI":"10.1523\/JNEUROSCI.3019-08.2008","article-title":"NMDA receptor activation by HIV-Tat protein is clade dependent","volume":"28","author":"W Li","year":"2008","journal-title":"J Neurosci"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"e11875","DOI":"10.1371\/journal.pone.0011875","article-title":"Nuclear factor-kappa B family member RelB inhibits human immunodeficiency virus-1 Tat-induced tumor necrosis factor-alpha production","volume":"5","author":"M Kiebala","year":"2010","journal-title":"PLoS One"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"e23915","DOI":"10.1371\/journal.pone.0023915","article-title":"HIV-1 Tat-induced microgliosis and synaptic damage via interactions between peripheral and central myeloid cells","volume":"6","author":"SM Lu","year":"2011","journal-title":"PLoS One"},{"key":"ref87","doi-asserted-by":"crossref","unstructured":"Chen L, Choi JJ, Choi YJ, Hennig B, Toborek M (2012) HIV-1 Tat-induced cerebrovascular toxicity is enhanced in mice with amyloid deposits. Neurobiol Aging.","DOI":"10.1016\/j.neurobiolaging.2011.06.004"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/BF03401701","article-title":"TNF-alpha opens a paracellular route for HIV-1 invasion across the blood-brain barrier","volume":"3","author":"M Fiala","year":"1997","journal-title":"Mol Med"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1097\/00002030-199912030-00005","article-title":"Evidence of blood-brain barrier alteration and activation in HIV-1 gp120 transgenic mice","volume":"13","author":"S Toneatto","year":"1999","journal-title":"AIDS"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/sj.jcbfm.9600330","article-title":"HIV-1 gp120 compromises blood-brain barrier integrity and enhances monocyte migration across blood-brain barrier: implication for viral neuropathogenesis","volume":"27","author":"GD Kanmogne","year":"2007","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1093\/jnen\/64.6.498","article-title":"HIV-1 gp120 proteins alter tight junction protein expression and brain endothelial cell permeability: implications for the pathogenesis of HIV-associated dementia","volume":"64","author":"GD Kanmogne","year":"2005","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref92","doi-asserted-by":"crossref","unstructured":"Singh MV, Davidson DC, Kiebala M, Maggirwar SB (2012) Detection of circulating platelet-monocyte complexes in persons infected with human immunodeficiency virus type-1. J Virol Methods.","DOI":"10.1016\/j.jviromet.2012.02.005"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1523\/JNEUROSCI.3863-05.2006","article-title":"CCL2\/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS","volume":"26","author":"EA Eugenin","year":"2006","journal-title":"J Neurosci"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/978-0-387-89520-8_2","article-title":"Therapeutic interventions targeting CD40L (CD154) and CD40: the opportunities and challenges","volume":"647","author":"CL Law","year":"2009","journal-title":"Adv Exp Med Biol"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1128\/CDLI.11.4.635-641.2004","article-title":"Targeting CD40L: a promising therapeutic approach","volume":"11","author":"D Daoussis","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"key":"ref96","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1212\/01.wnl.0000204294.28189.03","article-title":"Valproic acid adjunctive therapy for HIV-associated cognitive impairment: a first report","volume":"66","author":"G Schifitto","year":"2006","journal-title":"Neurology"},{"key":"ref97","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1089\/aid.2006.0311","article-title":"Platelet count is associated with plasma HIV type 1 RNA and disease progression","volume":"23","author":"G Rieg","year":"2007","journal-title":"AIDS Res Hum Retroviruses"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0051793","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T04:06:20Z","timestamp":1643861180000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0051793"}},"subtitle":[],"editor":[{"given":"Shilpa J.","family":"Buch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,12,12]]},"references-count":97,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2012,12,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0051793","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,12]]}}}